PI
FBIO icon

Pathlight Investors’s Fortress Biotech FBIO Stock Holding History

Pathlight Investors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$17K Buy
+953
New +$15.9K 0.01% 105

Other funds holding FBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.84B AUM 31.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pathlight Investors's FBIO Position: Q4 2018 in Review

Pathlight Investors opened a new position in Fortress Biotech (FBIO) in Q4 2018: 953 shares worth $17K. The stake represents 0.01% of the portfolio and ranks #105 among its holdings.

61 funds tracked by Wall St. Rank hold FBIO as of Q4 2018.

  • Pathlight Investors held 953 shares of Fortress Biotech worth $17K as of Q4 2018.
  • Fortress Biotech was a new Pathlight Investors position in Q4 2018.
  • Fortress Biotech made up 0.01% of Pathlight Investors's portfolio in Q4 2018, its #105 holding.
  • 61 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.